These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 4744578)

  • 21. Persistence of chromosome aberrations in peripheral lymphocytes from Hodgkin's lymphoma remission patients.
    Ryabchenko N; Nasonova V; Antoschina M; Fesenko E; Kondrashova T; Ivanova T; Pavlov V; Ryabikhina N; Terekhova A
    Int J Radiat Biol; 2003 Apr; 79(4):251-7. PubMed ID: 12775449
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Considerations in Hodgkin's disease].
    Pileri S; Falini B; Poggi S; Benni M; Bocchia M; Melilli G; Sabattini E; Tazzari PL; Stein H
    Pathologica; 1993; 85(1099):445-66. PubMed ID: 8127628
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chromosome changes in Hodgkin's disease.
    Seif GS; Spriggs AI
    J Natl Cancer Inst; 1967 Sep; 39(3):557-70. PubMed ID: 6053720
    [No Abstract]   [Full Text] [Related]  

  • 24. [Cytogenetic findings in Hodgkin's disease. Direct chromosome analysis in a case of paragranuloma].
    Messinetti S; Zelli GP; Marcellino LR; Alcini E
    Ann Ital Chir; 1966; 42(11):909-19. PubMed ID: 5999751
    [No Abstract]   [Full Text] [Related]  

  • 25. [Cytogenetics of malignant lymphoma].
    Fonatsch C
    Internist (Berl); 1993 Feb; 34(2):114-8. PubMed ID: 8454423
    [No Abstract]   [Full Text] [Related]  

  • 26. [Chromosome abnormalities in cancer, with special references to the significance and the assessment].
    Kamada N
    Rinsho Byori; 1989 Jul; (Spec No 82):87-97. PubMed ID: 2693768
    [No Abstract]   [Full Text] [Related]  

  • 27. Chromosome abnormalities and carcinogenesis.
    Pogosianz HE; Prigogina EL
    Neoplasma; 1972; 19(4):319-25. PubMed ID: 4262364
    [No Abstract]   [Full Text] [Related]  

  • 28. Aberrations of chromosome 3. A marker of T-cell lymphomas?
    Gödde-Salz E
    J Genet Hum; 1983 Mar; 31(1):39-44. PubMed ID: 6604789
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Study of chromosome abnormalities in Hodgkin's disease].
    Gastearena Erice J; Martínez-Peñuela JM; Lizaur Gomendio JL; Arcas Campoy P; Chacón Unzúe JM
    Rev Clin Esp; 1969 Jun; 113(5):453-4. PubMed ID: 5800552
    [No Abstract]   [Full Text] [Related]  

  • 30. Morphologically normal, CD30-negative B-lymphocytes with chromosome aberrations in classical Hodgkin's disease: the progenitor cell of the malignant clone?
    Jansen MP; Hopman AH; Bot FJ; Haesevoets A; Stevens-Kroef MJ; Arends JW; Jox A; Wolf J; Ramaekers FC; Schouten HC
    J Pathol; 1999 Dec; 189(4):527-32. PubMed ID: 10629553
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Viruses in human tumors. I. Hodgkin's disease.
    Stewart SE; Mitchell EZ; Whang JJ; Dunlop WR; Ben T; Nomura S
    J Natl Cancer Inst; 1969 Jul; 43(1):1-14. PubMed ID: 5804605
    [No Abstract]   [Full Text] [Related]  

  • 32. Aberrant and multiaberrant (rogue) cells in peripheral lymphocytes of Hodgkin's lymphoma patients after chemotherapy.
    Ryabchenko NI; Nasonova VA; Fesenko EV; Kondrashova TV; Antoschina MM; Pavlov VV; Ryabikina NV
    Mutat Res; 2006 Oct; 601(1-2):61-70. PubMed ID: 16828123
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cytogenetic observations on different cell lines in Hodgkin's disease.
    Olinici CD
    Acta Haematol; 1972; 48(5):283-7. PubMed ID: 4629533
    [No Abstract]   [Full Text] [Related]  

  • 34. Cytogenetic investigations in Hodgkin's disease: I. Involvement of specific chromosomes in marker formation.
    Fonatsch C; Diehl V; Schaadt M; Burrichter H; Kirchner HH
    Cancer Genet Cytogenet; 1986 Feb; 20(1-2):39-52. PubMed ID: 3455861
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk of non-Hodgkin's lymphoma and family history of lymphatic, hematologic, and other cancers.
    Chatterjee N; Hartge P; Cerhan JR; Cozen W; Davis S; Ishibe N; Colt J; Goldin L; Severson RK
    Cancer Epidemiol Biomarkers Prev; 2004 Sep; 13(9):1415-21. PubMed ID: 15342441
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis of ploidy and proliferative activity in childhood non-Hodgkin's lymphoma (NHL) and Hodgkin's disease (HD).
    Coad NA; Jones TJ; Muir KR; Parkes SE; Smith K; Raafat F; Mann JR
    Pediatr Pathol Lab Med; 1997; 17(6):893-902. PubMed ID: 9353829
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Specific marker chromosome 14 in malignant lymphomas.
    Fukuhara S; Shirakawa S; Uchino H
    Nature; 1976 Jan; 259(5540):210-11. PubMed ID: 765834
    [No Abstract]   [Full Text] [Related]  

  • 38. T-cell lymphoma developing in Hodgkin's disease: evidence for two clones.
    Wlodarska I; Delabie J; De Wolf-Peeters C; Mecucci C; Stul M; Verhoef G; Cassiman JJ; Van den Berghe H
    J Pathol; 1993 Jul; 170(3):239-48. PubMed ID: 8133397
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetic predisposition to Hodgkin's disease.
    Shpilberg O; Shahar A
    N Engl J Med; 1995 Jul; 333(1):64-5. PubMed ID: 7777004
    [No Abstract]   [Full Text] [Related]  

  • 40. Lymphomas and dysproteinaemias.
    Atkin NB
    Clin Haematol; 1980 Feb; 9(1):175-93. PubMed ID: 6768482
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.